43. 顕微鏡的多発血管炎 Disease details / Clinical trials / Drug dev / DR info

Active comparator
   Novartis Pharmaceuticals
      2025   Phase 2   NCT06868290   Israel;Japan;Singapore;United States
   University of Miyazaki Hospital
      2014   Phase 3   JPRN-UMIN000012409   Japan,North America,South America,Australia,Europe
Alemtuzumab
   Cambridge University Hospitals NHS Foundation Trust
      2011   Phase 4   NCT01405807   United Kingdom
Avacopan
   CHEMOCENTRYX, INC.
      2017   Phase 3   EUCTR2016-001121-14-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
   ChemoCentryx, Inc.
      2017   Phase 3   EUCTR2016-001121-14-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NO   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-FR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
   Kissei Pharmaceutical Co., Ltd.
      2022   -   NCT06758271   Japan
Azathioprine
   Assistance Publique - Hôpitaux de Paris
      2008   Phase 3   NCT00748644   France
      2003   Phase 3   NCT00307645   France;United Kingdom
   Cambridge University Hospitals NHS Foundation Trust
      2015   Phase 3   EUCTR2012-001102-14-CZ   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2012-001102-14-IT   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      2013   Phase 3   NCT01697267   Australia;Canada;Czech Republic;Czechia;Ireland;Italy;Japan;New Zealand;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001102-14-ES   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      -   Phase 3   EUCTR2012-001102-14-GB   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   Hospices Civils de Lyon
      1996   Phase 4   NCT00400075   Switzerland
   Human Genome Sciences Inc., a GSK Company
      2013   Phase 3   NCT01663623   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Norway;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
   National Institute of Allergy and Infectious Diseases (NIAID)
      2005   Phase 2/Phase 3   NCT00104299   Netherlands;United States
   Tokyo women's medical university Institute of rheumatology
      2018   Phase 2   JPRN-UMIN000024574   Japan
   University College Cork , Ireland
      2014   Phase 3   EUCTR2012-001102-14-IE   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Japan;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   University Hospital Birmingham NHS Foundation Trust
      2003   Phase 2   NCT00753103   United Kingdom
   University of Miyazaki Hospital
      2014   Phase 3   JPRN-UMIN000012409   Japan,North America,South America,Australia,Europe
Belimumab
   HUMAN GENOME SCIENCES INC
      2013   -   EUCTR2011-004569-33-IT   Australia;Belgium;Canada;Czech Republic;European Union;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
   Human Genome Sciences Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)
      2013   Phase 2   EUCTR2011-004569-33-DE   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
   Human Genome Sciences, Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)
      2013   Phase 3   EUCTR2011-004569-33-SE   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-004569-33-PL   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-004569-33-IE   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004569-33-HU   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004569-33-ES   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-004569-33-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-004569-33-BE   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004569-33-GB   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
Belimumab 10 MG/KG
   Human Genome Sciences Inc., a GSK Company
      2013   Phase 3   NCT01663623   Australia;Austria;Belgium;Brazil;Canada;Czech Republic;Czechia;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Norway;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
Benlysta 400 MG powder FOR concentrate FOR solution FOR infusion
   Human Genome Sciences Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)
      2013   Phase 2   EUCTR2011-004569-33-DE   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
   Human Genome Sciences, Inc. (a wholly owned subsidiary of GlaxoSmithKline PLC)
      2013   Phase 3   EUCTR2011-004569-33-SE   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-004569-33-PL   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-004569-33-IE   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004569-33-HU   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 3   EUCTR2011-004569-33-ES   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-004569-33-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2013   Phase 2   EUCTR2011-004569-33-BE   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
      2012   Phase 3   EUCTR2011-004569-33-GB   Australia;Austria;Belgium;Canada;Czech Republic;Finland;France;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Romania;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
Benlysta 400MG polvere PER concentrato PER soluzione PER infusione
   HUMAN GENOME SCIENCES INC
      2013   -   EUCTR2011-004569-33-IT   Australia;Belgium;Canada;Czech Republic;European Union;Germany;Hungary;India;Ireland;Italy;Mexico;Peru;Poland;Russian Federation;Spain;Sweden;Switzerland;United Kingdom;United States
Blisibimod
   Anthera Pharmaceuticals
      2014   Phase 2   NCT01598857   -
CCX168
   CHEMOCENTRYX, INC.
      2017   Phase 3   EUCTR2016-001121-14-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
   ChemoCentryx, Inc.
      2017   Phase 3   EUCTR2016-001121-14-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NO   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-FR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
CD19- bcma CAR-T cells
   Essen Biotech
      2024   Phase 1/Phase 2   NCT06350110   China
Cellcept
   Cambridge University Hospitals NHS Foundation Trust
      2008   Phase 2   EUCTR2006-001663-33-SE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom
   Mayo Clinic
      2002   Phase 1   NCT00405860   United States
   Vasculitis and Lupus Clinic
      2008   -   EUCTR2006-001663-33-IT   Austria;France;Germany;Italy;Spain;Sweden;United Kingdom
Chimeric monoclonal antibody, IGG4 subtype
   InflaRx GmbH
      2019   Phase 2   EUCTR2018-000768-27-SE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-NL   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IT   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-GB   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-ES   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DK   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-CZ   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
Corticosteroid and azathioprine
   Assistance Publique - Hôpitaux de Paris
      2008   Phase 3   NCT00647166   France
Cyclophosphamide
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 3   NCT00307645   France;United Kingdom
   Cambridge University Hospitals NHS Foundation Trust
      2008   Phase 2   EUCTR2006-001663-33-SE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom
      1998   Phase 2/Phase 3   NCT00430105   -
   Hospices Civils de Lyon
      1996   Phase 4   NCT00400075   Switzerland
   Masayoshi Harigai
      2018   Phase 2   JPRN-jRCT1091220325   Japan
   National Institute of Allergy and Infectious Diseases (NIAID)
      2005   Phase 2/Phase 3   NCT00104299   Netherlands;United States
   Ottawa Hospital Research Institute
      2025   Phase 3   NCT06983821   Canada
   Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology
      2013   -   JPRN-UMIN000011244   Japan
   University Hospital Birmingham NHS Foundation Trust
      2003   Phase 2   NCT00753103   United Kingdom
   University Medical Center Groningen
      2004   Phase 3   NCT00103792   Netherlands
   University of Parma
      2008   Phase 2   NCT00751517   Italy
   Vasculitis and Lupus Clinic
      2008   -   EUCTR2006-001663-33-IT   Austria;France;Germany;Italy;Spain;Sweden;United Kingdom
Cyclophosphamide, azathioprine,prednisone,methylprednisolone
   Assistance Publique - Hôpitaux de Paris
      2005   Phase 4   NCT00307671   France
Deltacortene
   AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
      2010   Phase 4   EUCTR2009-013220-24-IT   Czech Republic;Denmark;Italy;Poland;Spain;Sweden;United Kingdom
Endoxan baxter
   Vasculitis and Lupus Clinic
      2008   -   EUCTR2006-001663-33-IT   Austria;France;Germany;Italy;Spain;Sweden;United Kingdom
Galen® tablet
   InflaRx GmbH
      2019   Phase 2   EUCTR2018-000768-27-NL   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IT   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-ES   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
Glucocorticoids
   Chiba University
      2014   Phase 4   NCT02198248   Japan
   InflaRx GmbH
      2019   Phase 2   EUCTR2018-000768-27-SE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-NL   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IT   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-ES   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DK   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-CZ   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
   Massachusetts General Hospital
      2014   Phase 4   NCT02169219   United States
   Novartis Pharmaceuticals
      2025   Phase 2   NCT06868290   Israel;Japan;Singapore;United States
   University of Pennsylvania
      2010   Phase 3   NCT00987389   Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Greece;Italy;Japan;Mexico;New Zealand;Norway;Sweden;United Kingdom;United States
Glucocorticoids - reduced dose
   University of Pennsylvania
      2010   Phase 3   NCT03919825   -
Glucocorticoids - standard dose
   University of Pennsylvania
      2010   Phase 3   NCT03919825   -
Human normal immunoglobulin
   TEIJIN PHARMA LIMITED
      2014   Phase 3   JPRN-jRCT2080222344   Japan
Hydroxychloroquine
   Guy's and St Thomas' NHS Foundation Trust
      2020   Phase 4   NCT04316494   United Kingdom
Idefirix
   Charité - Universitätsmedizin Berlin
      2023   Phase 2   EUCTR2021-004706-22-DE   Germany
IFX-1
   InflaRx GmbH
      2019   Phase 2   NCT03895801   Belgium;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-SE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-NL   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IT   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-GB   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-ES   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DK   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-CZ   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2018   Phase 2   NCT03712345   Canada;United States
Imlifidase
   Charité - Universitätsmedizin Berlin
      2023   Phase 2   EUCTR2021-004706-22-DE   Germany
Immunoglobulin G cleaving cystein protease derived from E. coli
   Charité - Universitätsmedizin Berlin
      2023   Phase 2   EUCTR2021-004706-22-DE   Germany
Infliximab
   Assistance Publique - Hôpitaux de Paris
      2004   -   NCT00307593   France
   University Hospital Birmingham NHS Foundation Trust
      2003   Phase 2   NCT00753103   United Kingdom
Intravenous methyl prednisolone
   Cambridge University Hospitals NHS Foundation Trust
      1995   Phase 2/Phase 3   NCT01408836   United Kingdom
Mabthera
   Cambridge University Hospitals NHS Foundation Trust
      2014   Phase 3   EUCTR2012-001102-14-IT   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      2013   Phase 3   EUCTR2012-001102-14-ES   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      -   Phase 3   EUCTR2012-001102-14-GB   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   F. HOFFMANN - LA ROCHE LTD.
      2013   Phase 2   EUCTR2012-002062-13-IT   Germany;Italy;Turkey;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2013   Phase 2   EUCTR2012-002062-13-GB   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002062-13-DE   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
   University College Cork , Ireland
      2014   Phase 3   EUCTR2012-001102-14-IE   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Japan;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
Mabthera® 100MG
   Cambridge University Hospitals NHS Foundation Trust
      2015   Phase 3   EUCTR2012-001102-14-CZ   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
Mabthera® 500MG
   Cambridge University Hospitals NHS Foundation Trust
      2015   Phase 3   EUCTR2012-001102-14-CZ   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
Methotrexate
   Cambridge University Hospitals NHS Foundation Trust
      2015   Phase 3   EUCTR2012-001102-14-CZ   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2012-001102-14-IT   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      -   Phase 3   EUCTR2012-001102-14-GB   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   University College Cork , Ireland
      2014   Phase 3   EUCTR2012-001102-14-IE   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Japan;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   University of Parma
      2008   Phase 2   NCT00751517   Italy
Methylprednisolone
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 3   NCT00307645   France;United Kingdom
   National Institute of Allergy and Infectious Diseases (NIAID)
      2005   Phase 2/Phase 3   NCT00104299   Netherlands;United States
   University Hospital Birmingham NHS Foundation Trust
      2003   Phase 2   NCT00753103   United Kingdom
Mycophenolate
   University College Cork , Ireland
      2014   Phase 3   EUCTR2012-001102-14-IE   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Japan;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
Mycophenolate mofetil
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 3   NCT00307645   France;United Kingdom
   Cambridge University Hospitals NHS Foundation Trust
      2015   Phase 3   EUCTR2012-001102-14-CZ   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2012-001102-14-IT   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      2008   Phase 2   EUCTR2006-001663-33-SE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom
      -   Phase 3   EUCTR2012-001102-14-GB   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   Mayo Clinic
      2002   Phase 1   NCT00405860   United States
   University Hospital Birmingham NHS Foundation Trust
      2003   Phase 2   NCT00753103   United Kingdom
   University Medical Center Groningen
      2004   Phase 3   NCT00103792   Netherlands
Mycophenolate mofetil,methotrexate
   Assistance Publique - Hôpitaux de Paris
      2005   Phase 4   NCT00307671   France
Mycophenolic acid
   University College Cork , Ireland
      2014   Phase 3   EUCTR2012-001102-14-IE   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Japan;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   Vasculitis and Lupus Clinic
      2008   -   EUCTR2006-001663-33-IT   Austria;France;Germany;Italy;Spain;Sweden;United Kingdom
Naltrexone hydrochloride
   University of Pennsylvania
      2019   Phase 2   NCT03482479   Canada;United States
NO plasma exchange
   University of Pennsylvania
      2010   Phase 3   NCT00987389   Australia;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Greece;Italy;Japan;Mexico;New Zealand;Norway;Sweden;United Kingdom;United States
Obinutuzumab
   Mayo Clinic
      2023   Phase 2   NCT05376319   United States
Pednisone
   ChemoCentryx, Inc.
      2017   Phase 3   EUCTR2016-001121-14-NO   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-FR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
Plaquenil - hydroxychloroquine 200MG film coated tablets
   Guy's and St. Thomas' NHS Foundation Trust
      2020   Phase 4   EUCTR2018-001268-40-GB   United Kingdom
Plasma exchange
   Cambridge University Hospitals NHS Foundation Trust
      1995   Phase 2/Phase 3   NCT01408836   United Kingdom
   University Hospital Birmingham NHS Foundation Trust
      2003   Phase 2   NCT00753103   United Kingdom
Prednisolone
   Masayoshi Harigai
      2018   Phase 2   JPRN-jRCT1091220325   Japan
   University Hospital Birmingham NHS Foundation Trust
      2003   Phase 2   NCT00753103   United Kingdom
Prednison acis® 20 MG
   ChemoCentryx, Inc.
      2017   Phase 3   EUCTR2016-001121-14-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NO   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-FR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
Prednison acis® 5 MG
   ChemoCentryx, Inc.
      2017   Phase 3   EUCTR2016-001121-14-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NO   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-FR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
Prednison acis¿ 20 MG
   CHEMOCENTRYX, INC.
      2017   Phase 3   EUCTR2016-001121-14-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
Prednison acis¿ 5 MG
   CHEMOCENTRYX, INC.
      2017   Phase 3   EUCTR2016-001121-14-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
Prednisone
   AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
      2010   Phase 4   EUCTR2009-013220-24-IT   Czech Republic;Denmark;Italy;Poland;Spain;Sweden;United Kingdom
   Assistance Publique - Hôpitaux de Paris
      2003   Phase 3   NCT00307645   France;United Kingdom
   CHEMOCENTRYX, INC.
      2017   Phase 3   EUCTR2016-001121-14-IT   Australia;Austria;Belgium;Canada;Czech Republic;Czechia;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
   ChemoCentryx, Inc.
      2017   Phase 3   EUCTR2016-001121-14-SE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NO   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-NL   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-HU   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-GB   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-ES   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-DK   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-CZ   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-BE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      2017   Phase 3   EUCTR2016-001121-14-AT   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-IE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-FR   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
      -   Phase 3   EUCTR2016-001121-14-DE   Australia;Austria;Belgium;Canada;Czech Republic;Denmark;France;Germany;Hungary;Ireland;Italy;Netherlands;New Zealand;Norway;Spain;Sweden;Switzerland;United Kingdom;United States
   Hospices Civils de Lyon
      2018   Phase 3   EUCTR2018-001215-69-FR   France
   National Institute of Allergy and Infectious Diseases (NIAID)
      2005   Phase 2/Phase 3   NCT00104299   Netherlands;United States
   Ottawa Hospital Research Institute
      2025   Phase 3   NCT06983821   Canada
Prednisone tablets, USP
   InflaRx GmbH
      2019   Phase 2   EUCTR2018-000768-27-SE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-NL   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IT   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-IE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-GB   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-ES   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DK   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-CZ   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-BE   Belgium;Czech Republic;Denmark;France;Germany;Ireland;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
Prednisone, methylprednisolone,cyclophosphamides
   Assistance Publique - Hôpitaux de Paris
      2005   Phase 4   NCT00307671   France
Procalcitonin-variants elisa-assay
   University Hospital Muenster
      2022   -   NCT05703802   Germany
Rapcabtagene autoleucel
   Novartis Pharmaceuticals
      2025   Phase 2   NCT06868290   Israel;Japan;Singapore;United States
Rituximab
   Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
      2006   Phase 3   EUCTR2005-003610-15-CZ   Czech Republic;Sweden;United Kingdom
   Assistance Publique - Hôpitaux de Paris
      2020   Phase 3   NCT03920722   France
      2012   Phase 3   NCT01731561   France
      2008   Phase 3   NCT00748644   France
      2004   -   NCT00307593   France
   CHU de Saint-Etienne
      2015   Phase 4   EUCTR2015-001807-29-FR   France
   Cambridge University Hospitals NHS Foundation Trust
      2015   Phase 3   EUCTR2012-001102-14-CZ   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      2014   Phase 3   EUCTR2012-001102-14-IT   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      2013   Phase 3   NCT01697267   Australia;Canada;Czech Republic;Czechia;Ireland;Italy;Japan;New Zealand;Sweden;United Kingdom;United States
      2013   Phase 3   EUCTR2012-001102-14-ES   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
      -   Phase 3   EUCTR2012-001102-14-GB   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   Chiba University
      2014   Phase 4   NCT02198248   Japan
   F. HOFFMANN - LA ROCHE LTD.
      2013   Phase 2   EUCTR2012-002062-13-IT   Germany;Italy;Turkey;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2013   Phase 2   EUCTR2012-002062-13-GB   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002062-13-DE   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
   Genentech, Inc.
      2012   -   NCT01613599   United States
   Hoffmann-La Roche
      2013   Phase 2   NCT01750697   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
   Massachusetts General Hospital
      2014   Phase 4   NCT02169219   United States
   Mayo Clinic
      2023   Phase 2   NCT05376319   United States
   National Institute of Allergy and Infectious Diseases (NIAID)
      2005   Phase 2/Phase 3   NCT00104299   Netherlands;United States
   Ottawa Hospital Research Institute
      2025   Phase 3   NCT06983821   Canada
   University College Cork , Ireland
      2014   Phase 3   EUCTR2012-001102-14-IE   Australia;Austria;Canada;Czech Republic;Denmark;Germany;Ireland;Italy;Japan;Mexico;Netherlands;New Zealand;Poland;Spain;Sweden;Switzerland;United Kingdom
   University of Miyazaki Hospital
      2014   Phase 3   JPRN-UMIN000012409   Japan,North America,South America,Australia,Europe
Rixathon 500MG
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      2019   Phase 3   EUCTR2018-000637-12-FR   France
RO0452294/V01
   F. HOFFMANN - LA ROCHE LTD.
      2013   Phase 2   EUCTR2012-002062-13-IT   Germany;Italy;Turkey;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2013   Phase 2   EUCTR2012-002062-13-GB   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002062-13-DE   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
RO0452294/V02
   F. HOFFMANN - LA ROCHE LTD.
      2013   Phase 2   EUCTR2012-002062-13-IT   Germany;Italy;Turkey;United Kingdom;United States
   F. Hoffmann-La Roche Ltd.
      2013   Phase 2   EUCTR2012-002062-13-GB   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
      2013   Phase 2   EUCTR2012-002062-13-DE   Canada;France;Germany;Italy;Serbia;Turkey;United Kingdom;United States
RO106-1443
   Cambridge University Hospitals NHS Foundation Trust
      2008   Phase 2   EUCTR2006-001663-33-SE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom
SC291
   Sana Biotechnology
      2024   Phase 1   NCT06294236   United States
Sendoxan
   Cambridge University Hospitals NHS Foundation Trust
      2008   Phase 2   EUCTR2006-001663-33-SE   Austria;Czech Republic;France;Germany;Italy;Spain;Sweden;United Kingdom
Tocilizumab
   Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity
      2013   Phase 3   JPRN-UMIN000012072   Japan
   Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology
      2013   -   JPRN-UMIN000011244   Japan
      2013   -   JPRN-UMIN000011242   Japan
Vilobelimab
   InflaRx GmbH
      2019   Phase 2   EUCTR2018-000768-27-SE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;Switzerland;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-NL   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-DE   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
      2019   Phase 2   EUCTR2018-000768-27-CZ   Belgium;Czech Republic;Czechia;Denmark;France;Germany;Italy;Netherlands;Russian Federation;Spain;Sweden;United Kingdom
Vitamin D
   Christian Pagnoux
      2020   -   NCT04280601   Canada